trending Market Intelligence /marketintelligence/en/news-insights/trending/rkleqwtygfy8hpti56dlrw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Court sides with Pacific Biosciences in patent eligibility ruling

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Court sides with Pacific Biosciences in patent eligibility ruling

A U.S. court denied Oxford Nanopore Technologies Ltd's motion to dismiss a lawsuit filed by Pacific Biosciences of California Inc. for alleged patent infringement of its genome sequencing technology.

Judge Leonard Stark of the U.S. District Court for the District of Delaware denied the U.K.-based Oxford Nanopore's motion, which alleged that Pacific Biosciences' patent claims contain ineligible subject matter.

In November 2017, the U.S. District Court for the District of Delaware denied Oxford Nanopore's motion to dismiss another companion patent infringement case brought by Pacific Biosciences.

In a separate litigation in February, the U.S. International Trade Commission ruled that Oxford Nanopore did not infringe on Menlo Park, Calif.-based Pacific Biosciences' patents for certain molecule analysis devices.